| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/26/1998 | WO1998007745A2 Compositions and methods for treating infections using analogues of indolicidin |
| 02/26/1998 | WO1998007447A1 Anticonvulsant containing composition for treating neuropathic pain |
| 02/26/1998 | WO1998007445A1 Preventive/remedy for frequent urination and urinary incontinence |
| 02/26/1998 | WO1998007435A1 Eye treatments using synthetic thyroid hormone compositions |
| 02/26/1998 | WO1998007431A1 Cholinesterase inhibitors for treatment of parkinson's disease |
| 02/26/1998 | WO1998007426A1 Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes |
| 02/26/1998 | WO1998007422A1 Therapeutic treatment for sexual dysfunctions |
| 02/26/1998 | WO1998007321A1 Method for inhibiting the expression of fas |
| 02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/26/1998 | WO1997030701A3 Pharmaceutical compositions for the treatment of glaucoma |
| 02/26/1998 | CA2264182A1 Anticonvulsant containing composition for treating neuropathic pain |
| 02/26/1998 | CA2264178A1 Method for inhibiting the expression of fas |
| 02/26/1998 | CA2263890A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 02/26/1998 | CA2263799A1 Compositions and methods for treating infections using analogues of indolicidin |
| 02/26/1998 | CA2263659A1 Preventive/remedy for frequent urination and urinary incontinence |
| 02/26/1998 | CA2263556A1 Therapeutic treatment for sexual dysfunctions |
| 02/26/1998 | CA2263149A1 Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes |
| 02/26/1998 | CA2259310A1 Materials and methods for detection and treatment of immune system dysfunctions |
| 02/25/1998 | EP0825255A1 Method of producing activated killer monocytes |
| 02/25/1998 | EP0824917A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis |
| 02/25/1998 | EP0824594A1 Improved methods for transfecting t cells |
| 02/25/1998 | EP0824583A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 02/25/1998 | EP0824357A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 02/25/1998 | EP0824346A2 Use of sesquiterpenes for inhibiting oxidative enzymes |
| 02/25/1998 | CN1174513A Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 02/25/1998 | CN1174507A Antitumor agent potentiator comprising IL-6 antagonist |
| 02/24/1998 | US5721357 Depolymerizing heparin ester by action of a base to form sulfated oligosaccharides |
| 02/24/1998 | US5721278 Administering clomiphene and nitric oxide inducer |
| 02/24/1998 | US5721263 Angiotensin ii antagonist in combination with diuretic or calcium antagonist; treating hypertension |
| 02/24/1998 | US5721244 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 02/24/1998 | US5721215 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 02/24/1998 | US5720974 Compression molding mixture of active material, carbohydrate and water |
| 02/24/1998 | US5720966 Medicated tissue paper product |
| 02/24/1998 | US5720962 Analgesic lotion for hemorrhoids and method of making such lotion |
| 02/24/1998 | US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor |
| 02/24/1998 | US5720304 Diagnosis by conventional medical technique or bi-digital-o-ring test; having patient ingest antibiotic or antiviral agent, also ingest a herb concentration of umbelliferae family over sustained period of time |
| 02/24/1998 | CA2154103C Treatment of mucous membrane disease, trauma or condition and for the relief of pain |
| 02/23/1998 | CA2183901A1 Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans |
| 02/19/1998 | WO1998006847A1 Human dbi/acbp-like protein |
| 02/19/1998 | WO1998006841A2 Two human nsp-like proteins |
| 02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/19/1998 | WO1998006733A1 Nucleotide sequence encoding the cd33-like protein |
| 02/19/1998 | WO1998006697A1 Ether muscarinic antagonists |
| 02/19/1998 | WO1998006435A2 COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA) |
| 02/19/1998 | WO1998006433A1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 02/19/1998 | WO1998006423A1 Composition comprising insulin and insulin-like growth factor-i (igf-i) |
| 02/19/1998 | WO1998006417A1 Methods to treat cerebral ischemic injury and other neuronal diseases |
| 02/19/1998 | WO1998006412A1 A medicine of external use for treating seborrheic baldness with high efficacy and low side effect and preparation thereof |
| 02/19/1998 | WO1998006408A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | WO1998006407A1 Anthelmintic formulations |
| 02/19/1998 | WO1998006402A1 Treatment of the common cold or allergic rhinitis |
| 02/19/1998 | WO1998006394A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
| 02/19/1998 | WO1998006392A1 Formulation of 5-ht agonists |
| 02/19/1998 | WO1998006386A2 Derivates from bisaryltetracarbonacid, and pharmarceutical product containing them |
| 02/19/1998 | WO1998006379A1 Pharmaceutical compositions |
| 02/19/1998 | WO1998006265A2 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine |
| 02/19/1998 | WO1998006264A1 Plasmin-depletion therapy |
| 02/19/1998 | WO1997049805A3 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 02/19/1998 | DE19635352A1 Bisaryltetracarbonsäurederivate und diese enthaltende Arzneimittel Bisaryltetracarbonsäurederivate and pharmaceutical compositions containing them |
| 02/19/1998 | CA2263550A1 Treatment of the common cold or allergic rhinitis |
| 02/19/1998 | CA2263316A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | CA2263172A1 Two human nsp-like proteins |
| 02/19/1998 | CA2263169A1 Human dbi/acbp-like protein |
| 02/19/1998 | CA2263163A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
| 02/19/1998 | CA2263077A1 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound |
| 02/19/1998 | CA2261130A1 Methods to treat cerebral ischemic injury and other neuronal diseases |
| 02/18/1998 | EP0823942A1 Efflux pump inhibitors |
| 02/18/1998 | CN1173820A Pharmaceutical composition for the treatment of herpes |
| 02/18/1998 | CN1173817A Method, compsns and kits for increasing the oral bioavilability of pharmaceuticalagents |
| 02/18/1998 | CN1173330A Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitiors |
| 02/17/1998 | US5719185 Use for GABA agonists for treating emesis |
| 02/17/1998 | US5719160 Method for modifying and regulating lipid metabolism |
| 02/17/1998 | US5719136 Combination of progesterone antagonists and antiestrogens with partial agonistic action for hormone substitution therapy for perimenopausal and postmenopausal women |
| 02/17/1998 | US5719132 Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil |
| 02/17/1998 | CA2001727C Organic compounds |
| 02/12/1998 | WO1998005792A2 A novel human leptin receptor gene-related protein |
| 02/12/1998 | WO1998005782A1 Testis-specific insulin homolog polypeptides |
| 02/12/1998 | WO1998005779A1 Modified tie-2-receptor ligands |
| 02/12/1998 | WO1998005761A1 Age-1 polypeptides and related molecules and methods |
| 02/12/1998 | WO1998005360A2 Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes |
| 02/12/1998 | WO1998005356A1 NOVEL FtsL |
| 02/12/1998 | WO1998005351A1 Methods for regulating gastrointestinal motility |
| 02/12/1998 | WO1998005349A1 A novel method of detecting and treating cancer |
| 02/12/1998 | WO1998005347A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
| 02/12/1998 | WO1998005341A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 02/12/1998 | WO1998005340A1 Promotion of wound healing by chemically-modified tetracyclines |
| 02/12/1998 | WO1998005323A2 Method of regulating the female reproductive system through angiogenesis inhibitors |
| 02/12/1998 | WO1998005314A1 Novel stable liquid paracetamol compositions, and method for preparing same |
| 02/12/1998 | WO1998005302A1 Aerosol formulations |
| 02/12/1998 | WO1998005293A2 Method of regulating the female reproductive system through angiogenesis inhibitors |
| 02/12/1998 | WO1998005292A2 Piperidine and piperazine derivatives and their use as muscarinic antagonists |
| 02/12/1998 | WO1997047271A3 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 02/12/1998 | WO1997034599A3 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 02/12/1998 | CA2262624A1 A novel method of detecting and treating cancer |
| 02/12/1998 | CA2262535A1 Method of regulating the female reproductive system through angiogenesis inhibitors |
| 02/12/1998 | CA2261742A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 02/12/1998 | CA2261573A1 A novel human leptin receptor gene-related protein |
| 02/12/1998 | CA2260742A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
| 02/11/1998 | EP0823478A2 Human cartilage gp 39-like gene |
| 02/11/1998 | EP0823255A1 Pharmaceutical composition containing sucralfate |